Anti-IGFBP2 antibody
Specifications
| Product Cat#: | AB-06-2362 |
| Product type: | Primary antibody |
| Antigen: | IGFBP2 |
| Immunogen: | KLH conjugated synthetic peptide derived from human IGFBP2 101-200/305 |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:800-1:2000); Immunohistochemistry-Paraffin (1:500-800) |
| Reactivity: | Mouse, Rat and Human |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | BP 2 |
| BP2 | |
| IBP 2 | |
| IBP-2 | |
| IBP2 | |
| IBP2_HUMAN | |
| IGF binding protein 2 | |
| IGF BP53 | |
| IGF-binding protein 2 | |
| IGFBP 2 | |
| IGFBP-2 | |
| IGFBP2 | |
| IGFBP53 | |
| Insulin like growth factor binding protein 2 36kDa | |
| Insulin like growth factor binding protein 2 | |
| Insulin like growth factor-binding protein 2 precursor |
Show More
Target information
Inhibits IGF-mediated growth and developmental rates (By similarity). IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors.
Provider
Erpantech Laboratory